Revolutionising cancer treatment with Quantum AI
We empower oncologists with data-driven, personalised therapy recommendations for colorectal, breast, and lung cancer.

We empower oncologists with data-driven, personalised therapy recommendations for colorectal, breast, and lung cancer.
Data Analysis
We integrate clinical, genomic, and pharmacological datasets to understand patient-specific cancer profiles.
Quantum Machine Learning
Our neural network leverages quantum-enhanced algorithms to evaluate drug responses and predict IC50 values.
Therapy Recommendation
The system suggests the top three personalized therapies, enabling oncologists to make informed decisions quickly.
Precision
Tailored therapy options based on patient-specific data.
Speed
Faster decision-making with automated analysis.
Scientific Rigor
Grounded in validated datasets and IC50 drug response predictions.


Our platform combines Artificial Intelligence with Quantum Machine Learning to push the boundaries of oncology.
Neural networks trained on diverse datasets
Prediction of drug IC50 to evaluate efficacy
Focus on colorectal, breast, and lung cancers
Scalable architecture for future cancer types